{"id":"NCT01789970","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain","officialTitle":"A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Moderate to Severe Pain in Patients With Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03","primaryCompletion":"2014-02","completion":"2014-02","firstPosted":"2013-02-12","resultsPosted":"2017-04-05","lastUpdate":"2017-06-05"},"enrollment":625,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Low Back Pain"],"interventions":[{"type":"DRUG","name":"Hydrocodone ER","otherNames":["CEP-33237","Hydrocodone bitartrate extended-release tablets"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Hydrocodone ER","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the efficacy of hydrocodone bitartrate extended-release tablets at doses of 30 to 90 mg every 12 hours compared with placebo in alleviating moderate to severe pain in patients with chronic low back pain. Patients may be opioid-na√Øve or opioid-experienced.","primaryOutcome":{"measure":"Change From Baseline to Week 12 of the Treatment Period in Weekly Average of Daily Worst Pain Intensity (WPI)","timeFrame":"Days -6 to 0 of Treatment Period (baseline), Week 12 of Treatment Period","effectByArm":[{"arm":"Placebo (Double-blind Treatment Period)","deltaMin":0.71,"sd":0.145},{"arm":"Hydrocodone ER (Double-blind Treatment Period)","deltaMin":0.07,"sd":0.134}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":87,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":623},"commonTop":["Constipation","Nausea","Headache","Vomiting","Somnolence"]}}